The phrase "as testing platforms for" is correct and usable in written English.
It can be used when discussing tools, environments, or systems that are utilized for testing purposes in various contexts, such as software development or scientific research.
Example: "The new software tools are being developed as testing platforms for our upcoming applications."
Alternatives: "as evaluation tools for" or "as assessment environments for".
Although some developers are using the service for marketing purposes, it also has a growing number of enterprise customers who are using it as a sales and customer service tool, as well as a testing platform for internal use.
Here, we present a hierarchical sulfur cathode as a testing platform for understanding the high-loading capability of Li-S batteries.
Most of the recent Sony-Ericsson family of smartphones is provided with this sensor interface unit that is one of the main reasons for choosing the Sony Acro S model as a testing platform for the work discussed here.
This PDAC microtissue, closely recapitulating key PDAC microenvironment characteristics, provides a valuable tool to elucidate the complex stroma cancer interrelationship and could be used in a future perspective as a testing platform for anticancer drugs in tissue-on-chip technology.
The calibrated model was used as a testing platform for a number of hypothetical scenarios for which some experimental evidence was available either from the literature or from our lab.
This acted as, and continues to act as, a test platform for the Perl 6 language (separate from the development of the actual implementation) - allowing the language designers to explore.
LM1 can thus serve as pre-clinical testing platform for the role of CLTC-ALK in lymphomagenesis and developing molecular targeted therapy approaches for CLTC-ALK positive DLBCL.
This study is the first to evaluate the use of NGS technology as a diagnostic testing platform for inherited breast cancer in a South African cohort.
The mice have, for example, received significant attention as a preclinical testing platform for human hematopoiesis (Rongvaux et al., 2013; Tanner et al., 2014) and tissue regeneration (Isobe et al., 2014).
About 5 years ago, WES was heralded as the 'panel killer' and promoted as the one-stop testing platform for rare genetic diseases.
